Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check6 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor internal update to the page version. There are no visible changes to content or layout inferred from this revision.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.3 was added and v3.5.2 was removed, indicating a new build of the page/template. This change represents a behind-the-scenes update with no changes to the displayed study data or content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page footer now shows revision v3.5.2 and v3.5.0 was removed. This update does not change study content or how the page works.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check70 days agoChange Detected- The page revision tag was updated from v3.4.2 to v3.4.3. This is a minor metadata update and does not affect the page's content or functionality.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.4.2 to the page. The funding-status notices from earlier versions (lapse in government funding and related operating-status details) have been removed.SummaryDifference0.4%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.